• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Blogs » BioWorld MedTech Perspectives » Sundays with Peyton now not a pain in the neck

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

BioWorld MedTech / Orthopedics

Sundays with Peyton now not a pain in the neck

Nov. 20, 2013
By Robert Kimball

peyton It is fall here in the U.S. and, for many Americans, that time of year brings cooler weather and football. Apologies to our non-U.S. readers, I realize that you have ownership on “real” football, and our version is secular at best. But, hey, football is ours and we sure do like it.

It is during this time I like to reflect and “brag” that I have something in common with arguably one of the greatest quarterbacks to play the game – certainly in the modern era. You see, Peyton Manning and I share a common bond. No, my father wasn’t an NFL quarterback, I wasn’t an All-American quarterback at Tennessee, and my little brother hasn’t won two Super Bowls. Peyton and I both had identical cervical neck fusion surgery – and since then have both lived productive lives.

A quick history lesson. Manning opted for the fusion surgery in September 2011 after battling past problems with a bulging disc in his neck. There was no direct incident attributed to the injury, but no doubt the slings and arrows of his chosen profession were spotlighted. Manning sat out the whole 2011 season, and was subsequently released by his NFL team, the Indianapolis Colts in early 2012. Concern surfaced about Peyton’s ability to regenerate the nerve damage that had weakened his right (throwing) arm. But, given time, the nerve slowly regenerated. Imagine it like when your foot “falls asleep.” The nerve is pinched slightly and takes a few painful minutes to get back to normal. Manning’s neck had been like that for five years or more.

The Denver Broncos decided to take a chance on Manning and he was officially declared ready for the 2012 season. NFL fans nervously waited for him to take his first hit. Would he get up? Is his arm back to full strength? After an injury-free 2012 (including a trip to the playoffs), Manning is back better than ever in 2013. He threw for 400+ yards and 7 touchdowns in the Broncos’ opening game and is leading the NFL in QB rank. Many argue that he is better than ever, and the neck is in fact stronger than before surgery.

I had my surgery in March 2007, and it was the final stop for me following a year of cortisone injections, epidurals, physical therapy, pain meds, chiropractic treatment, and general frustration. Like Peyton, there was no direct cause of the bulging disk. Perhaps it was when I raked that last leaf in the yard, walked that extra block with the dog, moved the TV to another room? It doesn't matter. I was back to work in a month, and my right arm regained its strength, and although I don’t have to dodge NFL defense men, I hit the golf ball longer off the tee now than I ever did pre-surgery. I might have a tingling in my middle finger every now and then, but nothing serious.

What always amazes me is how far medicine, technology and surgery has come today. I often read or edit a story for Medical Device Daily featuring a new technology or an emerging company that is seeking funding for its new invention, and I think of how lucky we are to live in this day and age when medical technology is constantly improving. The research and development teams at device companies and universities is exciting. My surgeon told me that if it were 10 years earlier, I would have had “a chunk of metal” in my neck instead of the two miniature titanium plates. And my recovery would have been much more difficult.

So, for now, I am just glad that on Sunday afternoons my brother in surgery Peyton and I are in our rightful places – he on the playing field and I at home watching him from my couch.

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 28, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 28, 2025.
  • Boston Scientific Acurate Prime Aortic Valve System

    In TAVR setback, Boston Sci pulls plug on Acurate valves

    BioWorld MedTech
    Boston Scientific Corp. reported the latest setback in its transcatheter aortic valve replacement (TAVR) aspirations with the news that it is officially...
  • 3d rendering of bispecific antibodies

    Pfizer bets $6B+ on 3Sbio’s bispecific PD-1/VEGF antibody

    BioWorld
    Pfizer Inc. is paying $1.25 billion up front and up to $4.8 billion in milestone payments to gain global, ex-China rights to SSGJ-707, a PD-1/VEGF bispecific...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 27, 2025
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe